Senior Manager, Pre-Formulation and Formulation Development
Arvinas
Summary
The incumbent will combine hands-on pre-formulation expertise with practical oral and parenteral formulation development, moving flexibly between these functions as programs evolve. Responsibilities span compound characterization, animal and toxicology dosing formulations, and first-in-human and Phase 2 drug products, including formulation optimization and technology transfer. Working with the Drug Product Development team, the role will interpret data, recommend formulations, and deliver creative, phase-appropriate solutions across multiple early-stage programs. Priorities will be agreed with the Head of CMC Technical Operations who leads overall drug product strategy. This on-site role in New Haven, CT requires regular hands-on laboratory work and reports to the Head of CMC Technical Operations, with a dotted reporting line to the Drug Product Development.
Job description
Position Summary
The incumbent will combine hands-on pre-formulation expertise with practical oral and parenteral formulation development, moving flexibly between these functions as programs evolve. Responsibilities span compound characterization, animal and toxicology dosing formulations, and first-in-human and Phase 2 drug products, including formulation optimization and technology transfer. Working with the Drug Product Development team, the role will interpret data, recommend formulations, and deliver creative, phase-appropriate solutions across multiple early-stage programs. Priorities will be agreed with the Head of CMC Technical Operations who leads overall drug product strategy. This on-site role in New Haven, CT requires regular hands-on laboratory work and reports to the Head of CMC Technical Operations, with a dotted reporting line to the Drug Product Development.
Principal Responsibilities
- Plan and execute pre-formulation and formulation studies, balancing compound characterization, preclinical dosing needs, and Phase 1/2 formulation development against agreed priorities, material availability, and timelines.
- Characterize solubility, dissolution, solid-state and particle properties, chemical and physical stability, and excipient compatibility.
- Interpret analytical and relevant in vivo findings to recommend formulations with Drug Product Development.
- Develop oral and parenteral animal formulations for pharmacokinetic, efficacy, and non-GLP/GLP toxicology studies.
- Align vehicle, concentration, dose volume, route, tolerability, and preparation requirements with study teams.
- Establish dosing-formulation concentration, homogeneity, stability, robustness, and supported hold times with analytical specialists.
- Transfer reproducible procedures to CROs and resolve formulation issues with Toxicology, DMPK, and QA.
- Develop early clinical formulations, including spray-dried amorphous solid dispersions and tablets.
- Screen polymers, solvents, excipients, and processes and assess loading, stability, residual solvents, and dosage-form performance.
- Develop parenteral prototypes, evaluating pH, osmolality, stability, and dilution and administration compatibility.
- Apply PEG experience and biologics formulation knowledge, including aggregation and adsorption, with specialist support.
- Coordinate formulation testing, stability, in-use assessments, and clinical-scale transfer with Drug Product Development, Analytical Development, QA, and qualified manufacturing partners; identify comparison or bridging needs.
- Manage assigned vendor scopes, technical deliverables, timelines, and approved spend.
- Prepare development reports, formulation instructions, transfer packages, and relevant CMC content with traceable records and applicable GLP/cGMP compliance.
- Use focused experiments and documented risk assessments to advance programs efficiently under material, data, and time constraints.
- Mentor colleagues and maintain laboratory safety, product quality, and compliance.
Qualifications
- Strong hands-on pre-formulation and formulation experience, with repeated contributions to IND-enabling and early clinical programs.
- Ability to move between both functions and solve solubility and stability challenges creatively.
- Direct experience with oral and parenteral animal formulations, non-GLP/GLP study support, dose-formulation controls, and transfer to CROs or study sites.
- Spray drying and amorphous solid dispersion experience is required.
- Tableting and parenteral formulation development experience are required, including practical formulation evaluation and collaboration with manufacturing partners.
- Experience with PEG-containing drug candidates and working knowledge of biologics formulation, including protein stability, aggregation, adsorption, buffers, and excipients; ability to engage specialists appropriately.
- Ability to interpret physicochemical and analytical data, including relevant HPLC/UPLC, particle-size, DSC, TGA, and XRPD results.
- Working knowledge of GLP, early clinical cGMP, data integrity, and technology transfer.
- Strong experimental design, technical leadership, vendor management, communication, and mentoring skills.
- Later-stage and commercial experience are desirable, not required.
- Ability to perform essential on-site laboratory duties with appropriate PPE and reasonable accommodation, where needed.
- Arvinas will not be providing VISA sponsorship for this position now or in the future. You must have the ability to work without a need for current or future VISA sponsorship.
- The duties of this role are generally conducted in a combination of office and lab environment. Employees must be able, with or without an accommodation to lift/carry 15/30 pounds unassisted/assisted; work comfortable in a controlled environment with and around biological, infectious and hazardous materials; gown/degown PPE; use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving, analysis and dialogue; collaborate with others; maintain general availability during standard business hours.
Education
5+ years of relevant pharmaceutical or biotechnology experience in Pharmaceutics, Pharmaceutical Sciences, Chemistry, Chemical Engineering, or a related discipline, including hands-on pre-formulation and early formulation development, technical project leadership, and mentoring.
Requirements
- Strong hands-on pre-formulation and formulation experience, with repeated contributions to IND-enabling and early clinical programs.
- Ability to move between both functions and solve solubility and stability challenges creatively.
- Direct experience with oral and parenteral animal formulations, non-GLP/GLP study support, dose-formulation controls, and transfer to CROs or study sites.
- Spray drying and amorphous solid dispersion experience is required.
- Tableting and parenteral formulation development experience are required, including practical formulation evaluation and collaboration with manufacturing partners.
- Experience with PEG-containing drug candidates and working knowledge of biologics formulation, including protein stability, aggregation, adsorption, buffers, and excipients; ability to engage specialists appropriately.
- Ability to interpret physicochemical and analytical data, including relevant HPLC/UPLC, particle-size, DSC, TGA, and XRPD results.
- Working knowledge of GLP, early clinical cGMP, data integrity, and technology transfer.
- Strong experimental design, technical leadership, vendor management, communication, and mentoring skills.
- Later-stage and commercial experience are desirable, not required.
- Ability to perform essential on-site laboratory duties with appropriate PPE and reasonable accommodation, where needed.
- Arvinas will not be providing VISA sponsorship for this position now or in the future. You must have the ability to work without a need for current or future VISA sponsorship.
- 5+ years of relevant pharmaceutical or biotechnology experience in Pharmaceutics, Pharmaceutical Sciences, Chemistry, Chemical Engineering, or a related discipline, including hands-on pre-formulation and early formulation development, technical project leadership, and mentoring.
Benefits
- Group medical coverage
- Vision coverage
- Dental coverage
- Group life insurance
- Supplemental life insurance
- Incentive compensation
Company overview
Arvinas is a clinical-stage biotechnology company pioneering the development of targeted protein degradation therapeutics through its revolutionary PROTAC (PROteolysis TArgeting Chimeras) platform. Founded in 2013 and headquartered in New Haven, Connecticut, the company focuses on creating novel therapies that harness the body's natural protein disposal system to selectively degrade and remove disease-causing proteins. Arvinas is advancing multiple investigational drugs through clinical development programs, including vepdegestrant for ER+/HER2- breast cancer, ARV-393 for non-Hodgkin Lymphoma, and ARV-102 for neurodegenerative disorders. The company's PROTAC Discovery Engine represents a breakthrough approach that can target proteins previously considered 'undruggable' by traditional methods, offering potential advantages in oncology and neurology. With a team of 201-500 employees, Arvinas collaborates with leading pharmaceutical partners and academic institutions to accelerate its clinical programs and bring transformative treatments to patients with serious diseases.